Geographic & Priority Populations

Seroprevalence of SARS-CoV-2 among African Canadians: Clinical and Epidemiological Correlates

Upton Allen, Hospital for Sick Children (SickKids) Research Institute

In this study, researchers will follow people of African ancestry in Ontario to determine how many have had COVID-19 and to establish the risk factors associated with getting the infection as well as having poor outcomes, including hospitalization and death.
Research summary

COVID-19 Antibody Study

Philip Awadalla, Canadian Partnership for Tomorrow’s Health (CanPath)

Building on Canadian Partnership for Tomorrow’s Health (CanPath), a national population health research platform that follows the health of 330,000 Canadians, this pan-Canadian study tests 20,000 participants from high-risk populations for antibodies to SARS-CoV-2 (the virus that causes COVID-19), an indication of past infection.
Research summary Study website

The COVENANT Study: Homelessness and COVID-19

Stephen Hwang, Unity Health Toronto

The COVENANT study is gathering in-depth information on COVID-19 infections among people experiencing homelessness in Toronto, which has Canada’s largest homeless population.
Research summary Study website View study on

Action to beat Coronavirus in Canada (Ab‐C Study)

Prabhat Jha, CGHR, Unity Health and University of Toronto

Using dried blood spot (DBS) samples from about 10,000 randomly selected adults from across Canada taken at two separate intervals, the Action to Beat Coronavirus (Ab-C Study) aims to increase understanding of the durability of immunity against SARS-CoV-2 reinfection.
Research summary

Serologic prevalence of SARS-CoV-2 among provincial prison inmates in Quebec (SPIQ)

Nadine Kronfli, McGill University Health Centre

This study aims to determine previous exposure to the SARS-CoV-2 virus among incarcerated individuals and correctional staff in three provincial facilities, and contribute to a better understanding of immunity, transmission and burden of COVID-19 among these groups.
Research summary View study on

Accelerating SARS-CoV-2 SEroprevalence SurveyS Through Dried Blood Spots (COVID-19 ASSESS-DBS study)

Muhammad Morshed and Sophia Bartlett, BC Center for Disease Control

This study of 10 British Columbia correctional facilities is looking at blood samples from incarcerated individuals for COVID-19 antibodies to determine the prevalence of infection and help guide COVID-19 vaccine follow-up.
Research summary View study on

The serologic prevalence of SARS-CoV-2 amongst incarcerated persons in provincial correctional facilities in Saskatchewan

Alexander Wong, University of Saskatechewan

This study aim is to measure the prevalence of SARS-CoV-2 antibodies among incarcerated individuals in Regina, Saskatchewan.
Research summary View study on

SARS-CoV-2 antibody prevalence in federal and provincial correctional services in Canada

Jim Worthington, Corrections Canada

This study has two aims: to determine the prevalence of SARS-CoV-2 antibodies among people incarcerated at Correctional Service Canada (CSC) institutions, as well as staff; and to describe how incarcerated individuals’ antibodies change over time and how this might differ between subgroups (e.g. race, gender, chronic disease status, vaccine status).
Research summary View study on

LGBTQ2+ Studies

The COVID-19 pandemic and gay, bisexual, and other men who have sex with men

Daniel Grace, University of Toronto’s Dalla Lana School of Public Health

The study explores the direct and indirect impacts of the pandemic on gay, bisexual, and other men who have sex with men (GBM), including how COVID-19 is impacting mental health outcomes, experiences of loneliness, sexual behaviours, substance use patterns, and access to essential health care.
Research summary Study website View study on

COVID-19 among sexual- and gender-marginalized populations in Canada

Nathan Lachowsky, University of Victoria

Researchers are conducting an online survey of 2SLGBTQQI+ people across Canada to determine how COVID-19 impacts them. Participants may also provide blood to be tested for SARS-CoV-2 antibodies.
Research summary

See our other funded reseach studies

See our other funded reseach studies